Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/1991
11/12/1991CA1292015C 1-¬N-(.alpha.-AMINO-.alpha.-METHYLACETYL)AMINOPHENYL|-2-AMINOPROPANONE DERIVATIVES
11/12/1991CA1292005C Biphenyl hydroxamic acids
11/12/1991CA1292003C Hydroximic acids of 7-oxabicycloheptane substituted ethers and thioethers
11/12/1991CA1292000C Solid forms of 2-ethoxy-4-[n-(1-(2-piperidino- phenyl)-3-methyl-1-butyl)-aminocarbonylmethyl]-benzoic acid
11/12/1991CA1291999C Crystalline quinapril and a process for producing the same
11/12/1991CA1291995C N-substituted-arylalkyl and arylalkylene aminoheterocyclics as cardiovascular antihistaminic and antisecretory agents
11/12/1991CA1291994C Furo¬3,2-c|pyridine derivatives, their preparation and pharmaceutical compositions containing them
11/12/1991CA1291993C 1-vinyl isoquinoline compounds
11/12/1991CA1291991C Antioestrogenic phenol derivatives
11/12/1991CA1291990C Antiatherosclerotic tetrasubstituted ureas and thioureas
11/12/1991CA1291950C Cardiotonic aroylthiazolones
11/11/1991WO1991017160A1 Alkoxy-substituted dihydrobenzopyran-2-carboxylic acids and derivatives thereof
11/11/1991WO1991016903A2 Use of purine derivatives for anesthesia, analgesia and in vivo organ preservation
11/11/1991WO1991016897A1 Method, compositions, and compounds for modulating brain excitability
11/11/1991CA2082501A1 Method, compositions, and compounds for modulating brain excitability
11/11/1991CA2082500A1 Alkoxy-substituted dihydrobenzopyran-2-carboxylic acids and derivatives thereof
11/11/1991CA2042242A1 Complex of dideoxynucleoside and phosphonoformic acid
11/10/1991WO1991017163A1 IMIDAZO (4,5-c) PYRIDINES WITH PAF ANTAGONIST ACTIVITY
11/10/1991WO1991017162A1 Imidazopyridine paf antagonists
11/10/1991CA2080476A1 Azabenzimidazoles in the treatment of asthma, arthritis and related diseases
11/10/1991CA2078007A1 Imidazopyridine paf antagonists
11/10/1991CA2042126A1 Heterocyclic compounds
11/10/1991CA2041953A1 Pharmaceutical use of benzocycloheptathiophene-carboxylic acid derivatives
11/08/1991WO1991016913A1 Stabilized heparin solution
11/08/1991WO1991016905A1 Blocking the effect of teratogens on a fetus
11/08/1991WO1991016891A1 Treatment of chronic obstructive pulmonary disease (copd) by inhalation of an imidazoline
11/08/1991CA2081768A1 Treatment of chronic obstructive pulmonary disease (copd) by inhalation of an imidazoline
11/08/1991CA2080593A1 Blocking the effect of teratogens on a fetus
11/08/1991CA2062807A1 Stabilized heparin solution
11/08/1991CA2040750A1 Spiro dibenzosuberane derivatives
11/08/1991CA2016240A1 Substituted acetamide derivatives, process for their preparation and antiulcer drug containing same
11/07/1991DE4014252A1 (-)-1-(4'-Amino-3'-cyanophenyl)-2-iso-propyl-amino-ethanol - for treating fatty degeneration, obstructive lung disorders, allergic bronchial asthma, spastic bronchitis and premature labour
11/07/1991CA2016210A1 Use of aromatic aminoalkoxy derivatives for the treatment of troubles of the cerebrovascular system
11/06/1991EP0455599A1 Flavor enhancing and medicinal taste masking agent
11/06/1991EP0455596A1 Substituted Indoles
11/06/1991EP0455561A1 New pharmaceutical compositions containing polycarbophil
11/06/1991EP0455560A2 Use of N-dichloroacetyl lysogangliosides for the selective modulation of the expression and function of CD4 determinants on the cell surface
11/06/1991EP0455510A2 Use of 5-HT1A receptor agonist compounds for inhibiting gastric acid secretion
11/06/1991EP0455503A1 Composition for treating osteoporosis and hormonal imbalance
11/06/1991EP0455475A2 Use of triclosan in the treatment of diseases of the gastrointestinal tract
11/06/1991EP0455448A2 Treatment of pancreatic disease with 15-keto-prostaglandin compounds
11/06/1991EP0455432A1 Alpha-glycosyl naringin, and its preparation and uses
11/06/1991EP0455427A1 Deoxymacrolide derivatives having immunosuppressive activity
11/06/1991EP0455423A2 Ortho-lithiation process for the synthesis of 2-substituted 1-(tetrazol-5-yl) benzenes
11/06/1991EP0455356A1 Substituted 5-amino-1,2,4-thiadiazoles with pharmaceutical activity
11/06/1991EP0455271A2 Anti-inflammatory compositions
11/06/1991EP0455264A2 Ocular hypotensive agents
11/06/1991EP0455263A2 Non-pyrogenic and non-irritating composition comprising sodium hyaluronate
11/06/1991EP0455195A2 Ethanobicyclic amine derivatives for CNS disorders
11/06/1991EP0455159A1 4'-Demethylepipodophyllotoxin glycosides
11/06/1991EP0455155A1 Separation of cimaterol enantiomers
11/06/1991EP0455052A1 5-(1,2,4-Triazol-l-ylmethyl)-isoxazoline
11/06/1991EP0455042A1 Combination of pravastatin and a fibric acid derivative, and method for treating dyslipidemia using such combination
11/06/1991EP0455013A1 Ammoniumsalts of N(5)-methyl-5,6,7,8-tetrahydrofolic acid
11/06/1991EP0455006A2 Substituted 5-(2-((2-aryl-2-hydroxyethyl)amino)propyl)-1,3-benzodioxoles
11/06/1991EP0454818A1 Method for the preparation and purification of a mixture of glycosphingolipids free from contamination by non-conventional viruses
11/06/1991EP0454781A1 Recombinant cells for therapies of infection and hyperproliferative disorders and preparation thereof
11/06/1991EP0454773A1 Novel prodrug derivatives of biologically active agents containing hydroxyl groups or nh-acidic groups
11/06/1991EP0454736A1 Fibrinolysis by il-4
11/06/1991EP0454728A1 Fluorinated flavone acetic acid.
11/06/1991EP0454706A1 Reagents for the preparation of 5'-biotinylated oligonucleotides
11/06/1991EP0309477B1 Ecteinascidins 729, 743, 745, 759a, 759b and 770
11/06/1991EP0192713B1 Xenocoumacins
11/06/1991CN1055929A 2,9-disubstituted-4h-pyrido (1,2-a) pyrimidin-4-ones
11/06/1991CN1055928A Complexes of 3-morpholino-sydnonimine or its salts or its tautomer isomer, process for preparation thereof, and pharmaceutical compositions containing same
11/06/1991CN1055927A Benzimidazole derivatives, method for preparing same and use
11/06/1991CN1055925A Pyridine derivatives
11/06/1991CN1055876A Inhibitors of advanced glycosylation of proteins and method of use therefor
11/05/1991WO1991017246A1 Modulation of gene expression through interference with rna secondary structure
11/05/1991WO1991016898A1 Anti-fungal bile acid derivatives
11/05/1991US5063249 Nonirritating teat dip and method
11/05/1991US5063247 Anticholesterol enzyme inhibitors
11/05/1991US5063246 Hypotensive
11/05/1991US5063242 7-((substituted)amino)-8-((substituted)carbonyl)-methylamino-1-oxaspiro[4,5]decanes as diuretics antiinflammatory, and cerebrovascular agents
11/05/1991US5063240 Novel compounds
11/05/1991US5063239 Cardiovascular disorders
11/05/1991US5063238 Prevention of glycoprotein enveloped virus infectivity by pyridinyloxazole-2-ones
11/05/1991US5063237 Antiallergens and antiinflammatory agents
11/05/1991US5063234 Method of inhibiting demineralization of bone
11/05/1991US5063231 Gastrointestinal
11/05/1991US5063229 Imidazolo [1,2-a]pyrimidines and medical use thereof
11/05/1991US5063226 Use of supplemental dietary riboflavin to increase fertility and/or prolificacy in animals
11/05/1991US5063225 Benzothiazepines
11/05/1991US5063223 Method of controlling androstene levels in vivo with cobalt porphyrins
11/05/1991US5063222 Antiinflammatory dexamethasone 17α-cyclopropanecarboxylates with reduced systemic activity
11/05/1991US5063221 Treatment for hyperparathyroidism with use of vitamin d derivatives
11/05/1991US5063220 Parenteral formulations of 1-diphenylmethyl-4-((2-(4-methylphenyl)-5-methyl-1H-imidazol-4-yl)methyl)piperazine
11/05/1991US5063219 Anticoccidial composition
11/05/1991US5063210 Use of sulfated polysaccharides to decrease cholesterol and fatty acid absorption
11/05/1991US5063205 Epidermal growth factor
11/05/1991US5063064 Lithium fluoride
11/05/1991US5063061 Antiallergens
11/05/1991US5063060 Compositions and method for treating painful, inflammatory or allergic disorders
11/05/1991US5063056 Whitening skin
11/05/1991CA2081468A1 Anti-fungal bile acid derivatives
11/05/1991CA2041884A1 Process for the selective modulation of the expression and function of a determinant on the cell surface by means of appropriate chemical agents
11/05/1991CA2041799A1 Composition for treating osteoporosis and hormonal imbalance
11/05/1991CA2041745A1 Substituted indoles
11/05/1991CA2041712A1 Substituted 5-(2-((2-aryl-2-hydroxyethyl)amino)propyl)-1,3-benzodioxoles
11/05/1991CA2041687A1 Bis-aryl amide and urea antagonists of platelet activating factor
1 ... 7314 7315 7316 7317 7318 7319 7320 7321 7322 7323 7324 7325 7326 7327 7328 7329 7330 7331 7332 7333 7334 ... 7860